IRIS
LUGHEZZANI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.542
AS - Asia 8.805
EU - Europa 2.713
SA - Sud America 2.041
AF - Africa 511
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 15
Totale 26.649
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.236
SG - Singapore 5.387
BR - Brasile 1.670
CN - Cina 1.387
VN - Vietnam 974
IT - Italia 498
FI - Finlandia 493
IE - Irlanda 385
NG - Nigeria 327
DE - Germania 312
FR - Francia 249
HK - Hong Kong 229
GB - Regno Unito 191
CA - Canada 164
AR - Argentina 150
IN - India 140
NL - Olanda 121
TR - Turchia 112
BD - Bangladesh 102
SE - Svezia 89
RU - Federazione Russa 83
MX - Messico 79
ID - Indonesia 67
EC - Ecuador 59
IQ - Iraq 58
JP - Giappone 56
ZA - Sudafrica 52
UA - Ucraina 44
CL - Cile 41
VE - Venezuela 38
ES - Italia 35
IL - Israele 33
PL - Polonia 30
CO - Colombia 29
SA - Arabia Saudita 29
PH - Filippine 28
EG - Egitto 27
PK - Pakistan 27
PY - Paraguay 27
UZ - Uzbekistan 25
AU - Australia 22
DZ - Algeria 22
KE - Kenya 22
MA - Marocco 20
MK - Macedonia 20
RO - Romania 20
BE - Belgio 19
NP - Nepal 19
CZ - Repubblica Ceca 17
MY - Malesia 17
JO - Giordania 15
AT - Austria 14
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
KZ - Kazakistan 12
TN - Tunisia 12
TW - Taiwan 12
UY - Uruguay 11
DO - Repubblica Dominicana 10
A2 - ???statistics.table.value.countryCode.A2??? 9
LT - Lituania 9
PE - Perù 9
TT - Trinidad e Tobago 9
GR - Grecia 8
HN - Honduras 8
IR - Iran 8
JM - Giamaica 8
MO - Macao, regione amministrativa speciale della Cina 8
PT - Portogallo 8
AZ - Azerbaigian 7
ET - Etiopia 7
LB - Libano 7
PS - Palestinian Territory 7
AL - Albania 6
BO - Bolivia 6
TH - Thailandia 6
AO - Angola 5
CG - Congo 5
CR - Costa Rica 5
HU - Ungheria 5
MD - Moldavia 5
PA - Panama 5
RS - Serbia 5
BG - Bulgaria 4
DK - Danimarca 4
GT - Guatemala 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
EU - Europa 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
OM - Oman 3
SV - El Salvador 3
BS - Bahamas 2
Totale 26.612
Salva come PNG Salva come JPEG
Città #
Singapore 2.388
Wilmington 1.826
Chandler 1.314
Ashburn 839
The Dalles 800
San Mateo 717
Shanghai 602
San Jose 570
Dallas 529
Ann Arbor 512
Helsinki 491
Dublin 384
Leawood 330
Lawrence 327
Princeton 327
Benin City 325
Ho Chi Minh City 323
Beijing 278
New York 272
Hanoi 226
Boardman 222
Milan 216
Hong Kong 208
Paris 195
Fairfield 187
Woodbridge 186
Los Angeles 160
Santa Clara 156
São Paulo 105
Amsterdam 95
London 93
Toronto 78
Kocaeli 66
Buffalo 65
Rio de Janeiro 60
Orem 59
Council Bluffs 55
Da Nang 54
Haiphong 51
Seattle 50
San Diego 41
Belo Horizonte 37
Norwalk 35
Brasília 34
Columbus 33
Phoenix 32
Falkenstein 30
Rome 30
Campinas 29
Curitiba 29
Montreal 27
Munich 27
Naples 27
Pune 27
Chicago 24
Biên Hòa 23
Brooklyn 23
Frankfurt am Main 23
Porto Alegre 23
Tashkent 23
Chennai 22
Johannesburg 22
Manchester 22
Warsaw 22
Mexico City 21
Salvador 21
Tokyo 21
Nairobi 20
Thái Bình 20
Charlotte 19
Guayaquil 19
New Delhi 19
Falls Church 18
Guarulhos 18
Santiago 18
Atlanta 17
Brussels 17
Hải Dương 17
Moscow 17
Quito 16
Ribeirão Preto 16
Des Moines 15
Dhaka 15
Philadelphia 15
Houston 14
Redmond 14
Takamatsu 14
Amman 13
Boston 13
Can Tho 13
Fortaleza 13
Monmouth Junction 13
Mumbai 13
Recife 13
Riyadh 13
Asunción 12
Cairo 12
Kuala Lumpur 12
Manaus 12
Praia Grande 12
Totale 16.971
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 211
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 185
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 173
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 170
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 160
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 150
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 133
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 131
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 130
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 130
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 129
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 127
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 127
[Focal therapy and prostate cancer]. 126
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 126
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 125
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 124
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 123
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 120
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 117
Clinical and pathological predictors of persistent T1 HG at second resection 116
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 112
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 109
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 109
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 108
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 105
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 104
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 104
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 103
[The added value of robotic surgery]. 103
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis 103
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 101
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 101
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 100
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma 100
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 99
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 98
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 98
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 97
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 97
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 94
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 94
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study 93
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 93
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 92
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 92
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients 92
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 91
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study 91
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 90
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 90
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 90
The Management of Small Renal Masses: Renal Anatomy and Physiology 90
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 89
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 89
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 88
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 88
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 88
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 88
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 88
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 87
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting 87
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 87
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 87
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 85
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 85
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 84
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 84
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 84
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project 84
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 84
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 83
How Should We Report Incontinence After Radical Prostatectomy? 83
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 83
Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. 83
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 83
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 82
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 82
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 82
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 82
Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target 82
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 82
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 82
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 81
The relationship between continence and perineal body tone before and after radical prostatectomy: A pilot study 80
Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies 80
INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY 80
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 80
Nephron-sparing Surgery Is Equally Effective to Radical Nephrectomy for T1BN0M0 Renal Cell Carcinoma: A Population-based Assessment 80
Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer 79
MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE 79
Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms? 79
Intra-operative frozen section analysis to increase the rate of nerve-sparing procedures without compromising cancer control: Results from a contemporary population of patients treated with robotic assisted radical prostatectomy 79
Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223-5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction 78
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 78
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 78
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma 78
THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY. 77
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 77
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolò Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. 76
Totale 9.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 0 0 388
2021/20221.687 65 39 32 367 17 21 48 254 151 210 426 57
2022/20234.002 723 118 403 404 381 311 16 292 671 381 259 43
2023/20242.286 184 266 446 117 63 204 141 174 39 42 232 378
2024/20254.174 90 79 48 71 118 422 192 456 599 1.012 473 614
2025/202611.345 1.431 609 833 1.388 354 437 3.009 686 651 777 508 662
Totale 27.012